These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 19912520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA, Elliott C, Loughran KA, Kossar AP, Castillero E, Levy RJ, Ferrari G.
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [Abstract] [Full Text] [Related]

  • 4. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
    Aupperle H, Disatian S.
    J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease.
    Oyama MA, Chittur SV.
    Am J Vet Res; 2006 Aug; 67(8):1307-18. PubMed ID: 16881841
    [Abstract] [Full Text] [Related]

  • 7. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S, Orton EC.
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE, Singletary GE, Olsen LH, Wallace K, Häggström J, Ljungvall I, Höglund K, Reynolds CA, Pizzinat N, Oyama MA.
    J Vet Intern Med; 2014 Jan; 28(5):1534-40. PubMed ID: 25146933
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves.
    Lacerda CM, Maclea HB, Kisiday JD, Orton EC.
    J Vet Cardiol; 2012 Mar; 14(1):223-30. PubMed ID: 22364693
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in England.
    Mattin MJ, Boswood A, Church DB, López-Alvarez J, McGreevy PD, O'Neill DG, Thomson PC, Brodbelt DC.
    J Vet Intern Med; 2015 Mar; 29(3):847-54. PubMed ID: 25857638
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pathology of myxomatous mitral valve disease in the dog.
    Fox PR.
    J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
    [Abstract] [Full Text] [Related]

  • 19. Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study.
    Lu CC, Liu MM, Culshaw G, Clinton M, Argyle DJ, Corcoran BM.
    Vet J; 2015 Apr; 204(1):23-31. PubMed ID: 25841900
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.